Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 1

1(20.0%)

5Total

N/A(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04590209Not ApplicableWithdrawn

Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

Role: collaborator

NCT05328037Completed

Study on the Association Between Vitamin C Deficiency and Diarrhea in Children

Role: collaborator

NCT02619565Not ApplicableCompleted

Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes

Role: collaborator

NCT04253080Not ApplicableUnknown

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Role: collaborator

NCT03371056Not ApplicableUnknown

Maternal- Fetal Infection

Role: collaborator

NCT01084343Phase 1Completed

Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects

Role: collaborator

All 6 trials loaded